Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of Serratia marcescens IMP-1 expressed in Escherichia coli BL21 (DE3) using cephalothin as substrate preincubated for 5 mins followed by substrate addition relative to citrate
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of Serratia marcescens IMP-1 expressed in Escherichia coli BL21 (DE3) at 5 mM using cephalothin as substrate preincubated for 5 mins followed by substrate addition relative to control
Inhibition of Serratia marcescens IMP-1 expressed in Escherichia coli BL21 (DE3) at 5 mM using cephalothin as substrate preincubated for 5 mins followed by substrate addition
Enzyme Inhibition Assay from US Patent US10624871: "Bismuth(III) compounds and methods thereof"
Assay data:4 Active, 5 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
metallo-beta-lactamase inhibition assay from US Patent US11459296: "Antibacterial compounds"
Assay data:30 Active, 15 Activity ≤ 1 µM, 30 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Enzyme Activity: Determination of IC50 from US Patent US11207312: "Metallo-beta-lactamase inhibitors and methods of use thereof"
Assay data:204 Active, 130 Activity ≤ 1 nM, 204 Activity ≤ 1 µM, 204 Tested
Enzyme Activity: Determination of IC50 from US Patent US10544130: "Metallo-beta-lactamase inhibitors"
Assay data:489 Active, 328 Activity ≤ 1 nM, 489 Activity ≤ 1 µM, 489 Tested
beta-lactamase assay from US Patent US10543221: "Beta-lactamase inhibitors, formulations, and uses thereof"
Assay data:6 Active, 1 Activity ≤ 1 µM, 13 Tested
Enzyme Activity from US Patent US10227331: "Metallo-beta-lactamase inhibitors"
Assay data:369 Active, 307 Activity ≤ 1 nM, 369 Activity ≤ 1 µM, 369 Tested
MBL Inhibitory Activity in Constructed E. coli Cells Expressing MBLs from US Patent US10227327: "Inhibitors of metallo-beta-lactamase (MBL) comprising a zinc chelating moiety"
Assay data:11 Active, 9 Activity ≤ 1 µM, 11 Tested
BIOLOGICAL ASSAYS from US Patent US10221163: "Metallo-beta-lactamase inhibitors"
Assay data:492 Active, 462 Activity ≤ 1 nM, 492 Activity ≤ 1 µM, 492 Tested
Class B Enzyme Assay from US Patent US9708336: "Metallo-beta-lactamase inhibitors"
Assay data:825 Active, 169 Activity ≤ 1 nM, 823 Activity ≤ 1 µM, 825 Tested
qHTS to identify inhibitors of the New Delhi Metallo-beta-lactamase (NDM): primary screen against the NCATS Gemini Collection
Assay data:127 Activity ≤ 1 µM, 6933 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
qHTS to identify inhibitors of the New Delhi Metallo-beta-lactamase (NDM): Nitrocefin screen against the machine-based learning selections.
Assay data:6 Active, 1 Activity ≤ 1 nM, 13 Activity ≤ 1 µM, 2809 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
qHTS to identify inhibitors of the New Delhi Metallo-beta-lactamase (NDM): assay validation screen against the NCATS LOPAC Collection
Assay data:10 Active, 7 Activity ≤ 1 µM, 1248 Tested
qHTS to identify inhibitors of the New Delhi Metallo-beta-lactamase (NDM): Meropenem screen against the machine-based learning selections.
Assay data:1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2799 Tested
Inhibition of NDM-1 in Klebsiella pneumoniae using meropenem as substrate incubated for 0.5 hrs
Synergistic Inhibition of beta lactamase NDM1 in Klebsiella pneumoniae K66-45 assessed colony formation by visual inspection in presence of 50 microM (5-((4-iodophenylsulfonamido)methyl)-1H-1,2,3-triazol-4-yl)methyl acetate incubated for 20 hrs by two-fold dilution method
Synergistic Inhibition of beta lactamase NDM1 in Klebsiella pneumoniae K66-45 assessed colony formation by visual inspection in presence of 125 microM N-((4-((adamantylamino)methyl)-1H-1,2,3-triazol-5-yl)methyl)-4-iodobenzenesulfonamide incubated for 20 hrs by two-fold dilution method
Synergistic Inhibition of beta lactamase NDM1 in Klebsiella pneumoniae K66-45 assessed colony formation by visual inspection in presence of 125 microM N-((4-((cyclohexylamino)methyl)-1H-1,2,3-triazol-5-yl)methyl)-4-iodobenzenesulfonamide incubated for 20 hrs by two-fold dilution method
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on